Making Medicines affordable.

News Room

Press Releases

Media Kit

Press Releases

2003 and Before

2003/12/18

The European Generic Medicines Industry Endorses New Pharmaceutical Legislation adopted by the European Parliament in Strasbourg on Wednesday, 17th December.

2003/12/16

Despite concerns that the new EU Pharmaceutical Legislation will delay patient access to affordable healthcare, MEPs are recommended to accept the EU pharmaceuticals compromise.

2003/11/27

Today’s European Parliament Second Reading vote in the committee stage of the Review of EU Pharmaceutical Legislation gives a mixture of good and bad news for increasing patient access to affordable generics.

2003/11/24

Sustainable healthcare in Europe requires a strong and growing availability of affordable generic medicines, but this is now under threat from a series of amendments put forward in the European Parliament’s Second Reading of the Review of EU Pharmaceutical legislation.

2003/11/05

MEPs are under pressure to adopt a series of amendments in an EP draft report on human medicines presented this week in committee in second reading. The amendments from the draft report by Françoise Grossetête (F-EPP) are designed to hinder competition from affordable generic medicines in the EU pharmaceutical markets.

2003/09/08

The European Generics medicines Association (EGA) strongly supports the attached “Milan Declaration” on Generic Medicines made by the 10 EU Acceding Member States on Friday 5th September, warning of negative consequences of blocking low-priced generic medicines by increasing data exclusivity periods.

2003/07/08

Access to affordable medical care in EU Accession Countries is being jeopardized by the European Commission’s insistence on pushing through — before accession — controversial EU legislation on pharmaceuticals, which will delay the availability of competitively priced generic medicines.

2003/07/01

Portuguese Ministry of Health and Medicines Agency (INFARMED) wins EGA Award for their Consumer Information Campaign on Generic Medicines

2003/06/04

Monday’s decision by EU Health Ministers to increase the period of data exclusivity for branded products provides major advantages for originator pharmaceutical companies.

2003/04/22

Member States must significantly change the European Commission's modified proposal for EU pharmaceutical law if they wish to stimulate pharmaceutical competition and ensure affordability of medicines for EU consumers...

2003/02/10

Increasing generic prescribing, generic dispensing, and consumer awareness in generic medicines, as well as introducing more competitive price systems are the key stimulants for increasing generic competition in the EU. However, failures in the EU regulatory system ...

2002

2002/12/09

The European Generic medicine Association (EGA) has given its support to a series of measures and approaches for increasing the provision and development of affordable priced medicines to least developed countries.

2002/10/25

Measures by EU Governments to promote affordable Generic Medicines could be seriously undermined as a result of Wednesday’s vote in the European Parliament on new pharmaceutical legislation...

2002/05/27

Mismanagement of EU Accession in the area of pharmaceuticals will seriously undermine access to affordable medicines in Central and Eastern European Countries as well as undermine the EU’s own single market policy...

2002/01/24

“G10 on Medicines is making good progress and the series of G10 Workshops are providing an important avenue for increased participation and transparency,” says Andrew Kay, President of the EGA (European Generic medicines Association) and a Member of the G10 group on Medicines...

Pre-2002

2000/10/05

The European Generic medicines Association (EGA) will present this year its Generic Medicines Award, sponsored by Teva Europe, to Mr. Czeslaw Sobierajski, Member of the Polish Parliament, for his personal contribution in introducing the entitlement of advanced generic experimentation and registration (“Bolar”) into Polish legislation...

1998/04/02

LONDON. The European Generic medicines Association (EGA) announced here today that it will present the first EGA Generic medicines Award to the Dutch Institute for Effective Use of Medication (DGV) of the Netherlands, during the Association’s conference in London on April 2nd ...

The EGA

“In an era when increasing demands are being made on Europe’s healthcare services, generic medicines provide a major benefit to society as they ensure patient access to quality, safe and effective medicines while reducing the cost of medicinal care.”

The EGA is the official representative body of the European generic pharmaceuticals industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans while stimulating competitiveness and innovation in the pharmaceutical sector.

The EGA represents over 500 companies and their subsidiaries from greater Europe, and over 100,000 jobs. Generic medicines save €18 billion each year for health care systems and patients.

For further information: